<cite index="41-2">Intel priced 210.5 million shares at $95 on August 11, 2026, upsizing the offering from $15 billion to $20 billion with net proceeds of approximately $19.7 billion after fees</cite>. <cite index="41-2">The offering drew more than $100 billion in institutional demand, a roughly 5-to-1 oversubscription</cite>, signaling strong institutional conviction in Intel's AI chip and foundry strategy despite the 4.9% shareholder dilution.
<cite index="41-2">Intel raised its 2026 capital expenditure guidance to more than $20 billion, up from $18 billion, and CFO David Zinsner signaled further increases in 2027</cite>. The company is channeling the $20 billion offering into next-generation manufacturing nodes (14A targeting 2028 mass production), foundry expansion, and domestic fab buildout in Arizona and Ohio subsidized by US CHIPS Act funding. <cite index="42-2">Tesla has already signed as a 14A customer</cite>.
<cite index="41-4">Intel stock has surged 175% in 2026 and quintupled in value over the last year, making this equity issuance a conversion of share-price run into real manufacturing capacity without increasing debt</cite>. The institutional oversubscription reflects confidence that the growth funded by the raise outweighs dilution in a market where compute and fab capacity are structurally constrained.
For architects managing foundry or AI infrastructure decisions: Intel's $20B capital infusion signals intent to close the gap with TSMC and Samsung on advanced nodes while competing on inference-grade AI silicon costs. Tesla's 14A adoption provides early-stage proof. The equity raise over debt underscores that balance-sheet strength and access to public markets now matter more than quarterly margins in the capital-intensity race. Foundry customers seeking US-based supply should track 14A yield curves and Intel's ability to meet 2028 timelines, where execution risk remains high vs. TSMC.